Proteostasis and Ribostasis Impairment as Common Cell Death Mechanisms in Neurodegenerative Diseases

被引:6
|
作者
Lim, Su Min [1 ,2 ]
Nahm, Minyeop [3 ]
Kim, Seung Hyun [1 ,2 ,4 ,5 ]
机构
[1] Hanyang Univ, Coll Med, Cell Therapy Ctr, Seoul, South Korea
[2] Hanyang Univ, Coll Med, Dept Neurol, Seoul, South Korea
[3] Korea Brain Res Inst, Dementia Res Grp, Daegu, South Korea
[4] Hanyang Univ, Coll Med, Cell Therapy Ctr, 222 Wangsimni Ro, Seoul, South Korea
[5] Hanyang Univ, Coll Med, Dept Neurol, 222 Wangsimni Ro, Seoul, South Korea
来源
JOURNAL OF CLINICAL NEUROLOGY | 2023年 / 19卷 / 02期
基金
新加坡国家研究基金会;
关键词
proteostasis; ribostasis; neurodegenerative disease; liquid-liquid phase separation; cell death mechanism; FRONTOTEMPORAL LOBAR DEGENERATION; ALPHA-SYNUCLEIN AGGREGATION; RNA-BINDING PROTEINS; SUPEROXIDE-DISMUTASE; MESSENGER-RNA; LEWY BODY; MOLECULAR CHAPERONES; ALZHEIMER-DISEASE; PHASE-SEPARATION; MOUSE MODEL;
D O I
10.3988/jcn.2022.0379
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The cellular homeostasis of proteins (proteostasis) and RNA metabolism (ribostasis) are es-sential for maintaining both the structure and function of the brain. However, aging, cellular stress conditions, and genetic contributions cause disturbances in proteostasis and ribostasis that lead to protein misfolding, insoluble aggregate deposition, and abnormal ribonucleopro-tein granule dynamics. In addition to neurons being primarily postmitotic, nondividing cells, they are more susceptible to the persistent accumulation of abnormal aggregates. Indeed, de-fects associated with the failure to maintain proteostasis and ribostasis are common patho-genic components of age-related neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. Furthermore, the neuronal deposition of misfolded and aggregated proteins can cause both increased toxicity and impaired physio-logical function, which lead to neuronal dysfunction and cell death. There is recent evidence that irreversible liquid-liquid phase separation (LLPS) is responsible for the pathogenic ag-gregate formation of disease-related proteins, including tau, alpha-synuclein, and RNA-binding proteins, including transactive response DNA-binding protein 43, fused in sarcoma, and het-erogeneous nuclear ribonucleoprotein A1. Investigations of LLPS and its control therefore sug-gest that chaperone/disaggregase, which reverse protein aggregation, are valuable therapeutic targets for effective treatments for neurological diseases. Here we review and discuss recent studies to highlight the importance of understanding the common cell death mechanisms of and ribostasis in diseases.
引用
收藏
页码:101 / 114
页数:14
相关论文
共 50 条
  • [41] Could a Common Mechanism of Protein Degradation Impairment Underlie Many Neurodegenerative Diseases?
    Smith, David M.
    JOURNAL OF EXPERIMENTAL NEUROSCIENCE, 2018, 12
  • [42] Microarray gene expression analysis of common pathogenetic mechanisms in neurodegenerative diseases
    Durrenberger, P. F.
    Fernando, S.
    Kashefi, S. N.
    Consortium, B. N. E.
    Dexter, D. T.
    Reynolds, R.
    JOURNAL OF NEURAL TRANSMISSION, 2008, 115 (12) : 1730 - 1730
  • [43] Mechanisms underlying neural cell death in neurodegenerative diseases: alterations of a developmentally-mediated cellular rheostat
    Mehler, MF
    Gokhan, S
    TRENDS IN NEUROSCIENCES, 2000, 23 (12) : 599 - 605
  • [44] Natural Products as Modulators of the Proteostasis Machinery: Implications in Neurodegenerative Diseases
    Cuanalo-Contreras, Karina
    Moreno-Gonzalez, Ines
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (19)
  • [45] Mechanisms of cell death in neurodegenerative diseases: fashion, fiction, and facts (vol 12, pg 385, 2002)
    Thai, DR
    BRAIN PATHOLOGY, 2002, 12 (04) : CP1 - CP1
  • [46] Role of autophagy and proteostasis in neurodegenerative diseases: Exploring the therapeutic interventions
    Panwar, Surbhi
    Uniyal, Prerna
    Kukreti, Neelima
    Hashmi, Afreen
    Verma, Shivani
    Arya, Aanchal
    Joshi, Gaurav
    CHEMICAL BIOLOGY & DRUG DESIGN, 2024, 103 (04)
  • [47] Microglia programmed cell death in neurodegenerative diseases and CNS injury
    Cai, Ling
    Fan, Qiuyue
    Pang, Rui
    Chen, Chen
    Zhang, Yueman
    Xie, Haiyi
    Huang, Jingyi
    Wang, Yu
    Li, Peiying
    Huang, Dan
    Jin, Xia
    Zhou, Yuxi
    Li, Yan
    APOPTOSIS, 2025, 30 (1-2) : 446 - 465
  • [48] Regulated cell death: discovery, features and implications for neurodegenerative diseases
    Juntao Cui
    Suhan Zhao
    Yinghui Li
    Danyang Zhang
    Bingjing Wang
    Junxia Xie
    Jun Wang
    Cell Communication and Signaling, 19
  • [49] Role of sphingolipid-mediated cell death in neurodegenerative diseases
    Ariga, T
    Jarvis, WD
    Yu, RK
    JOURNAL OF LIPID RESEARCH, 1998, 39 (01) : 1 - 16
  • [50] Correlation of Ferroptosis and Other Types of Cell Death in Neurodegenerative Diseases
    Dang, Xiaoting
    Huan, Xuejie
    Du, Xixun
    Chen, Xi
    Bi, Mingxia
    Yan, Chunling
    Jiao, Qian
    Jiang, Hong
    NEUROSCIENCE BULLETIN, 2022, 38 (08) : 938 - 952